Alpha 2.0
Login Register
» Authors » Jeffrey P Graves

Jeffrey P Graves

Explore the profile of Jeffrey P Graves including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 5
Followers 0
Related Specialties
Dentistry
Neurosurgery
Otorhinolaryngology
Top 10 Co-Authors
Eric J Moore
Megan M J Bauman
Kathryn M Van Abel
Daniel L Price
Kendall K Tasche
Jamie J Van Gompel
David M Routman
Ghazal S Daher
Linda X Yin
Ryan A McMillan
Published In
Oral Oncol
Oper Neurosurg (Hagerstown)
J Neurosurg
Neurosurg Rev
Am J Otolaryngol
Affiliations
Soon will be listed here.
Recent Articles
1.
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis
Graves J, Daher G, Bauman M, Moore E, Tasche K, Price D, et al.
Oral Oncol . 2024 Sep; 159:107017. PMID: 39265195
No abstract available.
2.
Refining parotid acinic cell carcinoma treatment: Balancing risk factors and extent of resection
Graves J, Bukowski E, OByrne T, Yin L, Tasche K, Van Abel K, et al.
Am J Otolaryngol . 2024 Aug; 45(6):104446. PMID: 39096567
Objectives: Acinic cell carcinoma (ACC) most frequently arises in the parotid gland. Treatment consists of surgical resection and sometimes adjuvant therapy. ACC is most often a low-grade malignancy with good...
3.
Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection
Bauman M, Graves J, Haller T, McMillan R, Routman D, Raghunathan A, et al.
J Neurosurg . 2024 Mar; 141(3):711-719. PMID: 38518294
Objective: Olfactory neuroblastoma (ONB) is a rare, malignant tumor of the sinonasal tract that arises from olfactory epithelium. Although surgery is the preferred first-line treatment, tumor involvement of adjacent structures...
4.
Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis
Graves J, Daher G, Bauman M, Moore E, Tasche K, Price D, et al.
Oral Oncol . 2023 Oct; 147:106608. PMID: 37897858
Goal: We performed a systematic review of the literature and meta-analysis to determine how radiographic sarcopenia assessment methods and the presence of pre-treatment sarcopenia impact oncologic outcomes in patients with...
5.
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center
Abdel-Halim C, OByrne T, Graves J, Akpala C, Moore E, Price D, et al.
Oral Oncol . 2023 Sep; 146:106569. PMID: 37734203
Objectives: To investigate and describe the patterns of regional metastases and recurrences after surgical treatment of oropharyngeal squamous cell cancer (OPSCC). Materials And Methods: Retrospective study of patients diagnosed with...
6.
The utility of PET for detecting corticotropinomas in Cushing disease: a scoping review
Bauman M, Graves J, Harrison D, Hassett L, Bancos I, Johnson D, et al.
Neurosurg Rev . 2023 Jul; 46(1):160. PMID: 37393399
While magnetic resonance imaging (MRI) is the current standard imaging method for diagnosing and localizing corticotropinomas in Cushing disease, it can fail to detect adenomas in up to 40% of...
7.
Commentary: Endoscopic Endonasal Removal of a Laterally Extended Pituitary Adenoma Using Steerable Forceps: 2-Dimensional Operative Video
Bauman M, Graves J, Patra D, Marino M, Miglani A, Bendok B
Oper Neurosurg (Hagerstown) . 2022 Nov; 23(6):e392-e393. PMID: 36377910
No abstract available.